VANGUARD GROUP INC: CBIO position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of VANGUARD GROUP INC on CBIO, newest first. How the timeline and the estimate are built.
VANGUARD GROUP INC held 1,034,497 CBIO shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 1,034,497 sharesChange vs previous 13F +180,210 shares
<0.01% of the 13F portfolio, value $18,620,946.
13F-HR 0002100119-26-001527 filed by VANGUARD CAPITAL MANAGEMENT LLC
Filed (acceptance time not in the bulk data set), ingested- VANGUARD FIDUCIARY TRUST CO: 75,225 shares
- Vanguard Global Advisers, LLC: 2,714 shares
- VANGUARD CAPITAL MANAGEMENT LLC: 767,755 shares
- VANGUARD PORTFOLIO MANAGEMENT LLC: 188,803 shares
Acceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F/A 854,287 sharesChange vs previous 13F +296,781 shares
<0.01% of the 13F portfolio, value $15,693,253.
13F-HR/A 0002100119-26-001311 filed by VANGUARD CAPITAL MANAGEMENT LLC
Filed (acceptance time not in the bulk data set), ingested- VANGUARD FIDUCIARY TRUST CO: 49,423 shares
- Vanguard Global Advisers, LLC: 3,469 shares
- VANGUARD CAPITAL MANAGEMENT LLC: 801,395 shares
Acceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 557,506 sharesChange vs previous 13F -100,394 shares
<0.01% of the 13F portfolio, value $6,612,021.
13F-HR 0000102909-26-000031 filed by VANGUARD GROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 657,900 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $7,822,431.
13F-HR 0000102909-25-000353 filed by VANGUARD GROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).